drugset / Trial / NCT01106989

Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

NCT01106989

Phase 2 Completed 20 enrolled ZARS Pharma Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this pilot study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with myofascial trigger points.

Timeline

Start
2010-06
Primary completion
2010-12
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 70 mg Topical
Subject tetracaine Other / unclassified 70 mg Topical